SELLAS Life Sciences
SLS
SLS
30 hedge funds and large institutions have $6.44M invested in SELLAS Life Sciences in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
6% less funds holding
Funds holding: 32 → 30 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
30
Holding in Top 10
–
Calls
$4.75M
Puts
$217K
Top Buyers
| 1 | +$456K | |
| 2 | +$414K | |
| 3 | +$134K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$133K |
| 5 |
State Street
Boston,
Massachusetts
|
+$55.3K |
Top Sellers
| 1 | -$200K | |
| 2 | -$116K | |
| 3 | -$72.9K | |
| 4 |
Millennium Management
New York
|
-$57.9K |
| 5 |
VF
Virtu Financial
New York
|
-$39.8K |